Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 7, 2011, Pages 676-678

  Hazra, Monica ^a   Uchida, Hiroyuki ^a,c   Sproule, Beth ^a,b   Remington, Gary ^a,b   Suzuki, Takefumi ^c   Mamo, David C ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antipsychotic; monitoring; polypharmacy; prescription; schizophrenia

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ARTICLE; CANADA; HUMAN; MAJOR CLINICAL STUDY; PATIENT EDUCATION; PHARMACIST; POLYPHARMACY; PRESCRIPTION; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CANADA; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; HUMANS; INAPPROPRIATE PRESCRIBING; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; SCHIZOPHRENIA;

EID: 84255190969     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02280.x     Document Type: Article

References (7)

1. Pandurangi AK, Dalkilic A,. Polypharmacy with second-generation antipsychotics: A review of evidence. J. Psychiatr. Pract. 2008; 14: 345-367.
2. Robertson J, Walkom E, Pearson SA, Hains I, Williamsone M, Newby D,. The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: A systematic review of the literature. Int J Pharm Pract 2010; 18: 69-87.
3. Baandrup L, Allerup P, Lublin H, Nordentoft M, Peacock L, Glenthoj B,. Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients. Acta Psychiatr. Scand. 2010; 122: 367-374.
4. Thompson A, Sullivan SA, Barley M, et al,. The DEBIT trial: An intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards-a cluster randomized controlled trial. Psycho Med 2008; 38: 705-715. (Pubitemid 351483230)
5. Laska E, Siegel C, Simpson G,. Automated review system for orders of psychotropic drugs. Arch. Gen. Psychiatry 1980; 37: 824-827. (Pubitemid 10090650)
6. Brunk CG,. Public knowledge, public trust: Understanding the 'knowledge deficit'. Community Genet. 2006; 9: 178-183. (Pubitemid 43854182)
7. Ozdemir V, Muljono DH, Pang T, et al,. Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine. Curr. Pharmacogenomics Person. Med. 2011; 9: 1-5.